XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity is as follows:

 

 

 

Number of Options Outstanding

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (in Years)

 

 

Aggregate Intrinsic Value
(in thousands)

 

Balance at December 31, 2022

 

 

2,395,748

 

 

$

5.50

 

 

 

8.3

 

 

$

48

 

Options granted

 

 

1,665,505

 

 

 

4.63

 

 

 

 

 

 

 

Options exercised

 

 

(10,014

)

 

 

3.86

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(43,853

)

 

 

6.16

 

 

 

 

 

 

 

Balance at June 30, 2023

 

 

4,007,386

 

 

$

5.14

 

 

 

8.6

 

 

$

10,531

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at June 30, 2023

 

 

4,007,386

 

 

$

5.14

 

 

 

8.6

 

 

$

10,531

 

Options exercisable at June 30, 2023

 

 

1,472,165

 

 

$

5.30

 

 

 

7.5

 

 

$

4,089

 

Summary of Weighted Average Grant Date Fair Values and Weighted Average Assumptions used to calculate Fair Value of Options Granted

The following table presents the weighted-average assumptions used for the stock option grants for the three and six months ended June 30, 2023 and 2022, along with the related grant date fair value:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Stock price

$

7.32

 

 

$

4.70

 

 

$

4.63

 

 

$

4.63

 

Risk-free interest rate

 

3.82

%

 

 

2.83

%

 

 

3.83

%

 

 

2.06

%

Dividend yield

 

0.00

%

 

 

0.00

%

 

 

0.00

%

 

 

0.00

%

Expected volatility

 

78.05

%

 

 

75.15

%

 

 

77.60

%

 

 

75.20

%

Expected life (years)

 

5.7

 

 

 

5.7

 

 

 

6.0

 

 

 

6.0

 

Estimated grant date fair value per share of award granted

$

5.00

 

 

$

3.10

 

 

$

3.22

 

 

$

3.08

 

Schedule of Stock-Based Compensation Expense Recognized for all Equity Awards and Reported in the Statements of Operations and Comprehensive Loss

Stock-based compensation expense recognized for all equity awards has been reported in the statements of operations and comprehensive loss as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(in thousands)

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development

$

403

 

 

$

282

 

 

$

742

 

 

$

410

 

General and administrative

 

438

 

 

 

417

 

 

 

796

 

 

 

860

 

Total

$

841

 

 

$

699

 

 

$

1,538

 

 

$

1,270